You just read:

OncoGenex Pharmaceuticals, Inc. Announces Phase 2 Apatorsen Data for Two Clinical Trials Presented at the American Society of Clinical Oncology (ASCO) 2017 Genitourinary Cancers Symposium

News provided by

OncoGenex Pharmaceuticals, Inc.

21 Feb, 2017, 09:00 ET